AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines for AqVida’s Cancer-fighting Paclitaxel Injectable Finished Dosage Formulation

By |2019-04-18T21:06:38-08:00April 18th, 2019|

AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines.

Go to Top